AR007211A1 - Una formulacion de cristal de proteina de enlazamiento cruzado, metodos para producirla y para incrementar su actividad, un biosensor y un dispositivoextra-corporal que emplean dicha formulacion - Google Patents

Una formulacion de cristal de proteina de enlazamiento cruzado, metodos para producirla y para incrementar su actividad, un biosensor y un dispositivoextra-corporal que emplean dicha formulacion

Info

Publication number
AR007211A1
AR007211A1 ARP970102139A ARP970102139A AR007211A1 AR 007211 A1 AR007211 A1 AR 007211A1 AR P970102139 A ARP970102139 A AR P970102139A AR P970102139 A ARP970102139 A AR P970102139A AR 007211 A1 AR007211 A1 AR 007211A1
Authority
AR
Argentina
Prior art keywords
formulation
methods
biosensor
cross
extra
Prior art date
Application number
ARP970102139A
Other languages
English (en)
Spanish (es)
Original Assignee
Altus Biologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altus Biologics Inc filed Critical Altus Biologics Inc
Publication of AR007211A1 publication Critical patent/AR007211A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ARP970102139A 1996-05-24 1997-05-20 Una formulacion de cristal de proteina de enlazamiento cruzado, metodos para producirla y para incrementar su actividad, un biosensor y un dispositivoextra-corporal que emplean dicha formulacion AR007211A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/652,964 US5932212A (en) 1996-05-24 1996-05-24 Crosslinked protein crystal formulations and their use as catalysts in organic solvents

Publications (1)

Publication Number Publication Date
AR007211A1 true AR007211A1 (es) 1999-10-13

Family

ID=24618946

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970102139A AR007211A1 (es) 1996-05-24 1997-05-20 Una formulacion de cristal de proteina de enlazamiento cruzado, metodos para producirla y para incrementar su actividad, un biosensor y un dispositivoextra-corporal que emplean dicha formulacion

Country Status (13)

Country Link
US (2) US5932212A (en:Method)
EP (1) EP0906417B1 (en:Method)
JP (2) JP4279351B2 (en:Method)
KR (1) KR20000015993A (en:Method)
AR (1) AR007211A1 (en:Method)
AT (1) ATE393216T1 (en:Method)
AU (1) AU3072897A (en:Method)
DE (1) DE69738648T2 (en:Method)
DK (1) DK0906417T3 (en:Method)
ID (1) ID17817A (en:Method)
IN (1) IN191060B (en:Method)
WO (1) WO1997044445A1 (en:Method)
ZA (1) ZA974325B (en:Method)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009750A1 (en) * 1990-11-29 1992-06-11 Willis Richard R Floating contaminant containment systems
US6140475A (en) * 1997-04-11 2000-10-31 Altus Biologics Inc. Controlled dissolution crosslinked protein crystals
NZ502246A (en) * 1997-06-20 2002-10-25 Univ New York Electrospraying solutions of biologically active substances (proteins) on a substrate for mass fabrication of chips and libraries
US6833275B1 (en) * 1997-07-22 2004-12-21 Roche Diagnostics Gmbh Gold conjugates containing detergent
ES2306477T3 (es) * 1997-09-05 2008-11-01 Altus Pharmaceuticals Inc. Cristales de glicoproteina reticulados por carbohidratos.
US6500933B1 (en) 1997-09-05 2002-12-31 Altus Biologics Inc. Methods of preparing carbohydrate crosslinked glycoprotein crystals
ZA988461B (en) * 1997-09-18 1999-03-30 Idec Pharma Corp Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis
US6541606B2 (en) * 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
CA2330476A1 (en) * 1998-04-27 1999-11-04 Altus Biologics Inc. Stabilized protein crystals, formulations containing them and methods of making them
US6979561B1 (en) 1998-10-09 2005-12-27 Gilead Sciences, Inc. Non-homogeneous systems for the resolution of enantiomeric mixtures
CA2346702C (en) * 1998-10-09 2012-05-29 Altus Biologics Inc. Non-homogeneous systems for the resolution of enantiomeric mixtures
DE19903125B4 (de) * 1999-01-27 2006-01-05 Sanofi-Aventis Deutschland Gmbh Verfahren zur Trocknung von Kristallen von Insulin oder Insulinanaloga
AU6574400A (en) * 1999-08-18 2001-03-13 Hydrios Biotechnology Oy Process for the preparation and simultaneous separation of enzyme-catalysed products
US7521216B2 (en) * 1999-12-29 2009-04-21 Verenium Corporation Nitrilases and methods for making and using them
US20040014195A1 (en) * 1999-12-29 2004-01-22 Diversa Corporation Nitrilases, nucleic acids encoding them and methods for making and using them
US7608445B1 (en) 1999-12-29 2009-10-27 Verenium Corporation Nitrilases, nucleic acids encoding them and methods for making and using them
US7300775B2 (en) 1999-12-29 2007-11-27 Verenium Corporation Methods for producing α-substituted carboxylic acids using nitrilases and strecker reagents
US20010046493A1 (en) * 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
WO2001090733A1 (en) * 2000-05-23 2001-11-29 Radiometer Medical A/S A sensor membrane, a method for the preparation thereof, a sensor and a layered membrane structure for such sensor
WO2002072636A2 (en) * 2000-12-28 2002-09-19 Altus Biologics Inc. Crystals of whole antibodies and fragments thereof and methods for making and using them
EP1492554B1 (en) 2001-06-21 2019-08-21 Althea Technologies, Inc. Spherical protein particles
AU2003251523A1 (en) 2002-06-13 2003-12-31 Diversa Corporation Processes for making (r)-ethyl 4-cyano-3-hydroxybutyric acid
US9035123B2 (en) 2002-10-01 2015-05-19 The Procter & Gamble Company Absorbent article having a lotioned topsheet
KR20050094832A (ko) * 2002-12-31 2005-09-28 알투스 파마슈티컬스 인코포레이티드 단백질 결정과 이온성 중합체를 함유하는 복합체
WO2004060310A2 (en) * 2002-12-31 2004-07-22 Altus Pharmaceuticals Inc. Human growth hormone crystals and methods for preparing them
DK1699921T3 (da) * 2004-01-01 2010-02-01 Council Scient Ind Res Fremgangsmåde til fremstilling af tværbundne proteinkrystaller
DK2198880T3 (en) * 2004-10-14 2017-01-23 Lilly Co Eli Compositions containing lipase, protease and amylase for the treatment of pancreatic insufficiency
WO2007050100A2 (en) * 2004-11-24 2007-05-03 Industrial Science & Technology Network, Inc. Immobilized enzymes and processes for preparing and using same
US20060223765A1 (en) * 2005-03-30 2006-10-05 Kimberly-Clark Worldwide, Inc. Method for inhibiting and/or treating vaginal infection
GB0513888D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
US20100196344A1 (en) * 2005-10-14 2010-08-05 Cystic Fibrosis Foundation Therapeutics, Inc. Compositions and methods for treating pancreatic insufficiency
WO2007076131A2 (en) * 2005-12-23 2007-07-05 Altus Pharmaceuticals Inc. Compositions comprising polycation-complexed protein crystals and methods of treatment using them
US20100047413A1 (en) * 2006-09-15 2010-02-25 Cabalka Tourtellotte Leanne M Method of using amphiphilic multiblock copolymers in food
WO2008106662A2 (en) 2007-03-01 2008-09-04 Verenium Corporation Nitrilases, nucleic acids encoding them and methods for making and using them
IL183084A0 (en) * 2007-05-09 2007-09-20 Trans Biodisel Ltd Modified-immobilized enzymes of high tolerance to hydrophilic substrates in organic media
CN101717766B (zh) * 2009-12-01 2012-07-18 暨南大学 蛋白质酶的微水介质固定化方法
EP2588597A4 (en) 2010-06-30 2013-12-25 Codexis Inc CHEMICALLY MODIFIED CARBOHYDRED ANHYDRASES SUITABLE FOR CARBON STORAGE SYSTEMS
US9303255B2 (en) 2010-08-26 2016-04-05 Aisin Seiki Kabushiki Kaisha Electrode having enzyme crystals immobilized thereon, method for producing electrode having enzyme crystals immobilized thereon, and biological fuel cell and biosensor provided with electrode having enzyme crystals immobilized thereon

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267234A (en) * 1978-03-17 1981-05-12 California Institute Of Technology Polyglutaraldehyde synthesis and protein bonding substrates
US4369226A (en) * 1979-03-19 1983-01-18 California Institute Of Technology Polyglutaraldehyde synthesis and protein bonding substrates
US5152903A (en) * 1988-12-19 1992-10-06 American Cyanamid Company Cross-linked cationic polymeric microparticles
IE912767A1 (en) * 1990-08-03 1992-02-12 Vertex Pharma Use of crosslinked crystals as a novel form of enzyme¹immobilization
GB9309243D0 (en) * 1993-05-05 1993-06-16 Allied Colloids Ltd Enzyme dispersions,their production and compositions containing them
WO1994028118A1 (en) * 1993-05-20 1994-12-08 Loders Croklaan B.V. Immobilized lipases
BR9408185A (pt) * 1993-12-03 1997-05-27 Buckman Labor Inc Método para estabilizar uma composiçao de enzima e composiçao de enzima
DE4344211A1 (de) * 1993-12-23 1995-06-29 Basf Ag Verfahren zur Erhöhung der Aktivität von hydrolytischen Enzymen

Also Published As

Publication number Publication date
DK0906417T3 (da) 2008-07-21
JP4279351B2 (ja) 2009-06-17
ZA974325B (en) 1997-12-18
EP0906417A1 (en) 1999-04-07
JP2008061652A (ja) 2008-03-21
US6042824A (en) 2000-03-28
IN191060B (en:Method) 2003-09-13
US5932212A (en) 1999-08-03
KR20000015993A (ko) 2000-03-25
DE69738648T2 (de) 2009-05-28
DE69738648D1 (de) 2008-06-05
ID17817A (id) 1998-01-29
ATE393216T1 (de) 2008-05-15
EP0906417B1 (en) 2008-04-23
AU3072897A (en) 1997-12-09
WO1997044445A1 (en) 1997-11-27
JP2000514282A (ja) 2000-10-31

Similar Documents

Publication Publication Date Title
AR007211A1 (es) Una formulacion de cristal de proteina de enlazamiento cruzado, metodos para producirla y para incrementar su actividad, un biosensor y un dispositivoextra-corporal que emplean dicha formulacion
FI862282L (fi) Medel foer test av oeverkaenslighet.
BR8906988A (pt) Tetrapiptidio,peptidio,composicao farmaceutica,processo para uso de peptidio e reagente para diagnostico
TR200000565T2 (tr) Biyolojik örneklerdeki analiz bileşenlerinin hızlı analizi için yöntem
ES2170100T3 (es) Procedimiento y sistema analitico mejorados para la realizacion de ensayos de fibrinogeno con precision, rapidez y sencillez.
EP1496350A3 (en) Method and apparatus for generating basis sets for use in spectroscopic analysis
DK0988533T3 (da) Biosensor omfattende en lipidmembran indeholdende styrede io kanaler
TR200001789T2 (tr) Prolamin-bitki kutuplu lipit kompozisyonu, bunun hazırlama ve uygulama metodu
DE60031506D1 (de) Fasermatrix zum zusammenbringen von chemischen stoffen, sowie verfahren zur herstellung und anwendung davon
PT1053043E (pt) Montagens de recolha para sistemas de amostragem transdermica
DE3861132D1 (de) Dismulgierendes und reinigungsmittel, verwendbar zur trennung von erdoel-wasser-gemischen, gegebenenfalls emulsionen und anwendungen dieses mittels.
NL7805215A (nl) Membraaneenheid, inrichting met membraaneenheid en werkwijze voor het zuiveren van bloed.
ATE97740T1 (de) Kontrollierte farbton-vorrichtung.
DK0770876T3 (da) En screening-fremgangsmåde til at identificere ligander for målproteiner
ATE205401T1 (de) Lokale behandlung von psoriasis unter verwendung neutralisierender antikörper gegen il-8
IT7819499A0 (it) Proteina biologicamente attiva fissata su poliamide e processo per la sua preparazione.
NL187936B (nl) Werkwijze en inrichting voor het bepalen van de alcoholconcentratie van bloed.
BR9607679B8 (pt) Uso de bicarbornato de potássio, composição farmacêutica, e, processo para tratar esofagite de refluxo, gastrite, dispepsia ou ulceração péptica.
ES2154736T3 (es) Metodo de analisis.
ATE395433T1 (de) Screeningverfahren für geeignete wirkstoffe
EP1343006A4 (en) METHOD FOR DETERMINING THE PROFILE OF A PROTEIN
NO901535L (no) Molekylaersikter og anvendelse derav som oksydasjonskatalysator.
MX9706437A (es) Proceso y compuestos para la deteccion de analitos usando medicion de remanencia y el uso de los mismos.
TR199900596T2 (xx) Otoim�n hastal�klara kar�� maddeler olarak proteinlerin kullan�m�.
ES2153580T3 (es) Complejos quimicos.